and is 40 + % effective - delivery - safe - ) this in it’s self is a marketable product. Fine it’s not the rocket to the moon everyone hoped for and management handled this poorly - this and the coming products will make up a range of products and as the supplier, process, administration and lessons learnt are applied
if this was a bust at 40% compared to 50% competitors with some serious side affects I’m missing something, by the way these first phases were an on going process for the real prize of antibacterial
What's the vehicle anyhow?, page-39
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 650314 | 19 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |